MetaAnalysis of NOACs vs Warfarin RCT vs RealWorld Data Screening for Atrial Fibrillation to Prevent Strokes Silent AF Screening for AF Devices for LongTerm AF Screening Regular Pulse Check for Detecting AF ID: 776667
Download Presentation The PPT/PDF document " Management of Atrial Fibrillation, Stro..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Management of Atrial Fibrillation, Stroke, and Bleeding
Slide2Meta-Analysis of NOACs vs Warfarin
Slide3RCT vs Real-World Data
Slide4Screening for Atrial Fibrillation to Prevent Strokes
Slide5Silent AF
Slide6Screening for AF
Slide7Devices for Long-Term AF Screening
Slide8Regular Pulse Check for Detecting AF
Slide9Implantable vs Handheld Devices for Detecting AF
Slide10Implications of Screening and Detecting AF
Slide11NOAC-Related Intracranial Hemorrhage
Slide12Incidence of ICH in NOAC-Treated Patients
Slide13Predictors of ICH
Slide14Handling Patients With ICH
Slide15Slide16Resuming Anticoagulation After a Bleed
Slide17Oral Anticoagulants
Slide18Clinical Trials vs "Real-World" Studies
Slide19Sources of Data in AF With NOAC
Slide20Registry DataUse of Low Doses of NOACs
Slide21Misconceptions About NOAC Doses
Slide22Registry DataExtremes of Age and Weight
Slide23Registry DataAdherence
Slide24Take-Home Messages
Slide25NOACs
Slide26Meta-Analysis of NOACs vs Warfarin
Slide27Use of PCC in NOAC-Related ICH
Slide28Specific Reversal Agents
Slide29Indications for Reversal Agents
Slide30NOAC Assays
Slide31Dosing Strategies for Idarucizumab vs Andexanet Alfa
Slide32Abbreviations
Slide33Abbreviations (cont)